Grantham, Mayo, Van Otterloo & Co (GMO)
CSLT

Grantham, Mayo, Van Otterloo & Co (GMO)’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CSLT Stock Details CSLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10,700
Closed -$35K – 808
2019
Q2 		$35K Buy
+10,700
New +$36.9K ﹤0.01% 698

Other funds holding CSLT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CSLT Position: Q3 2019 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q3 2019, closing a stake of 10,700 shares — an estimated $35K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CSLT in Q2 2019 and held it in 1 quarter. The position peaked at $35K in Q2 2019. 99 funds tracked by Wall St. Rank hold CSLT as of Q3 2019.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining CASTLIGHT HEALTH, INC. position as of Q3 2019 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,700 CASTLIGHT HEALTH, INC. shares in Q3 2019, an estimated $35K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CASTLIGHT HEALTH, INC. in Q2 2019 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CASTLIGHT HEALTH, INC. position peaked at $35K in Q2 2019.
  • 99 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q3 2019.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2019, filed 13 Nov 2019.